BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12826274)

  • 1. Mutagenesis studies of the human MT2 melatonin receptor.
    Gerdin MJ; Mseeh F; Dubocovich ML
    Biochem Pharmacol; 2003 Jul; 66(2):315-20. PubMed ID: 12826274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding.
    Gubitz AK; Reppert SM
    Endocrinology; 2000 Mar; 141(3):1236-44. PubMed ID: 10698201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term exposure to melatonin differentially affects the functional sensitivity and trafficking of the hMT1 and hMT2 melatonin receptors.
    Gerdin MJ; Masana MI; Ren D; Miller RJ; Dubocovich ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):931-9. PubMed ID: 12604667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor.
    Conway S; Mowat ES; Drew JE; Barrett P; Delagrange P; Morgan PJ
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1229-36. PubMed ID: 11302748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor.
    Mseeh F; Gerdin MJ; Dubocovich MI
    Eur J Pharmacol; 2002 Aug; 449(1-2):29-38. PubMed ID: 12163103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor.
    Conway S; Drew JE; Mowat ES; Barrett P; Delagrange P; Morgan PJ
    J Biol Chem; 2000 Jul; 275(27):20602-9. PubMed ID: 10770942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.
    Brydon L; Roka F; Petit L; de Coppet P; Tissot M; Barrett P; Morgan PJ; Nanoff C; Strosberg AD; Jockers R
    Mol Endocrinol; 1999 Dec; 13(12):2025-38. PubMed ID: 10598579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
    Dubocovich ML; Masana MI; Iacob S; Sauri DM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):365-75. PubMed ID: 9089668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important amino acids for the function of the human MT1 melatonin receptor.
    Kokkola T; Foord SM; Watson MA; Vakkuri O; Laitinen JT
    Biochem Pharmacol; 2003 May; 65(9):1463-71. PubMed ID: 12732358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors.
    Reppert SM
    J Biol Rhythms; 1997 Dec; 12(6):528-31. PubMed ID: 9406026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First cloning and functional characterization of a melatonin receptor in fish brain: a novel one?
    Gaildrat P; Becq F; Falcón J
    J Pineal Res; 2002 Mar; 32(2):74-84. PubMed ID: 12071471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
    Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
    J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the melatonin-binding site MT3 as the quinone reductase 2.
    Nosjean O; Ferro M; Coge F; Beauverger P; Henlin JM; Lefoulon F; Fauchere JL; Delagrange P; Canet E; Boutin JA
    J Biol Chem; 2000 Oct; 275(40):31311-7. PubMed ID: 10913150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
    Witt-Enderby PA; Dubocovich ML
    Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
    Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
    Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
    Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes.
    Poon AM; Choy EH; Pang SF
    Biol Signals Recept; 2001; 10(6):367-79. PubMed ID: 11721092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of valine 208 and histidine 211 in ligand binding and receptor function of the ovine Mel1a beta melatonin receptor.
    Conway S; Canning SJ; Barrett P; Guardiola-Lemaitre B; Delagrange P; Morgan PJ
    Biochem Biophys Res Commun; 1997 Oct; 239(2):418-23. PubMed ID: 9344844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel isoforms of Mel1c melatonin receptors modulating intracellular cyclic guanosine 3',5'-monophosphate levels.
    Jockers R; Petit L; Lacroix I; de Coppet P; Barrett P; Morgan PJ; Guardiola B; Delagrange P; Marullo S; Strosberg AD
    Mol Endocrinol; 1997 Jul; 11(8):1070-81. PubMed ID: 9212055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of melatonin receptors and 2-[125I]iodomelatonin binding sites in the pituitary of a teleost fish.
    Gaildrat P; Falcón J
    Adv Exp Med Biol; 1999; 460():61-72. PubMed ID: 10810501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.